Sex: M
Vaccine: COVID19, UNK
Symptoms: Acarodermatitis, Arthritis, Arthropod bite, Herpes zoster, Prostatic specific antigen
Clinical narrative: Shingles from covid vaccine; Arthritis came back; Auto accident; Scabies; Bit by spider; Psoriasis came back with SKYRIZI (RISANKIZUMAB); This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles from covid vaccine), ARTHRITIS (Arthritis came back), ROAD TRAFFIC ACCIDENT (Auto accident), ACARODERMATITIS (Scabies) and ARTHROPOD BITE (Bit by spider) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Psoriasis.    The patient's past medical history included Arthritis. Concurrent medical conditions included Psoriasis.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced HERPES ZOSTER (Shingles from covid vaccine), ARTHRITIS (Arthritis came back), ROAD TRAFFIC ACCIDENT (Auto accident), ACARODERMATITIS (Scabies), ARTHROPOD BITE (Bit by spider) and PSORIASIS (Psoriasis came back with SKYRIZI (RISANKIZUMAB)). At the time of the report, HERPES ZOSTER (Shingles from covid vaccine), ARTHRITIS (Arthritis came back), ROAD TRAFFIC ACCIDENT (Auto accident), ACARODERMATITIS (Scabies), ARTHROPOD BITE (Bit by spider) and PSORIASIS (Psoriasis came back with SKYRIZI (RISANKIZUMAB)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Prostatic specific antigen: PSA level high.         No concomitant medications were reported.  On an unspecified date, the patient underwent prostate biopsy and results was unknown.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  No treatment medications were reported.  The reporter's causality for the events of arthritis came back, auto accident, scabies, bit by spider, shingles from COVID vaccine and psoriasis came back was not provided against risankizumab. The reporter causality for event shingles from COVID vaccine was reported as probably related with Moderna COVID-19 vaccine.  Company comment  This spontaneous case concerns a male patient of unknown age, with relevant medical history of Arthritis and having concurrent illness with Psoriasis, who experienced the non-serious, unexpected AESI of ARTHRITIS (Arthritis came back), unknown days after receiving the 2 dose of mRNA 1273 vaccine, in the covid 19 vaccination series, along with other non serious event of psoriasis flare up. On an unknown date, the patient was started on RISANKIZUMAB for Psoriasis, which along with medical history of Arthritis could be considered as confounders for the flare up of Arthritis. The outcome of the event was unknown. On an unknown date, Prostatic specific antigen (PSA) level was high and underwent prostate biopsy with results unknown. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a male patient of unknown age, with relevant medical history of Arthritis and having concurrent illness with Psoriasis, who experienced the non-serious, unexpected AESI of ARTHRITIS (Arthritis came back), unknown days after receiving the 2 dose of mRNA 1273 vaccine, in the covid 19 vaccination series, along with other non serious event of psoriasis flare up. On an unknown date, the patient was started on RISANKIZUMAB for Psoriasis, which along with medical history of Arthritis could be considered as confounders for the flare up of Arthritis. The outcome of the event was unknown. On an unknown date, Prostatic specific antigen (PSA) level was high and underwent prostate biopsy with results unknown. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report